HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,010,672 | -81.7% | 120,430 | -83.8% | 0.01% | -78.3% |
Q2 2023 | $76,359,053 | +173.4% | 742,414 | +190.1% | 0.02% | +155.6% |
Q1 2023 | $27,929,690 | -87.9% | 255,902 | -87.4% | 0.01% | -88.6% |
Q4 2022 | $231,062,000 | +22.0% | 2,030,321 | -33.9% | 0.08% | +12.9% |
Q3 2022 | $189,448,000 | -7.3% | 3,070,573 | +19.5% | 0.07% | -1.4% |
Q2 2022 | $204,427,000 | +47.1% | 2,569,012 | +94.5% | 0.07% | +73.2% |
Q1 2022 | $138,996,000 | -39.6% | 1,320,991 | -38.2% | 0.04% | -35.9% |
Q4 2021 | $230,308,000 | -17.8% | 2,138,133 | -16.3% | 0.06% | -28.1% |
Q3 2021 | $280,046,000 | +7.5% | 2,555,160 | -8.3% | 0.09% | +9.9% |
Q2 2021 | $260,629,000 | +3.5% | 2,786,776 | +2.1% | 0.08% | -3.6% |
Q1 2021 | $251,777,000 | +138.0% | 2,730,327 | +88.7% | 0.08% | +121.1% |
Q4 2020 | $105,789,000 | -12.5% | 1,447,083 | -6.8% | 0.04% | -22.4% |
Q3 2020 | $120,908,000 | +55.9% | 1,552,013 | +11.8% | 0.05% | +48.5% |
Q2 2020 | $77,534,000 | +28.3% | 1,387,940 | -31.9% | 0.03% | +3.1% |
Q1 2020 | $60,417,000 | -48.8% | 2,039,183 | -37.4% | 0.03% | -34.7% |
Q4 2019 | $118,082,000 | +23.4% | 3,257,782 | -7.2% | 0.05% | +14.0% |
Q3 2019 | $95,711,000 | +16.6% | 3,511,097 | +2.9% | 0.04% | +16.2% |
Q2 2019 | $82,083,000 | – | 3,413,021 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |